drugset / Trial / NCT02908334
Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
RandomizedCrossoverOpen-labelTreatment
Summary
In this study patients will be randomized 1:2 to receive either standard of care treatment or standard of care + Sertraline 200mg/day for 2 weeks, then 400 mg/day for 50 weeks for treatment of disseminated and meningeal coccidioidomycosis.
Timeline
- Start
- 2016-11
- Primary completion
- 2019-01-22
- Completion
- 2019-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sertraline | Small molecule | 400 mg | — |